Beyond Inflammation: Uncovering the Direct Role of JAK Signalling in Pain Modulation

12:00 pm - Thursday 28th January 2027

  • Evaluating clinical and translational evidence suggesting JAK inhibition may alleviate pain independently of its anti-inflammatory effects
  • Exploring how JAK-mediated cytokine signalling influences sensory neuron activity and pain processing across immune-mediated diseases
  • Understanding why pain often remains the primary unmet need for patients despite successful suppression of inflammatory biomarkers
  • Identifying opportunities to leverage immune-pain biology to develop more effective therapies for inflammatory and non-inflammatory pain conditions

Speakers:

Head of Rheumatology Early Discovery (Immunology R&D)
Abbvie